Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Etoricoxib tablets bulk supplier for pharma manufacturers

Etoricoxib Tablets 60 mg, 90 mg, 120 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 60 mg, 90 mg, 120 mg

Reference Brands: Arcoxia (EU)

Category: Arthritis

Etoricoxib selectively inhibits the COX-2 enzyme, reducing prostaglandin synthesis responsible for pain and inflammation. It provides effective relief in rheumatoid arthritis and osteoarthritis, with a lower risk of gastrointestinal side effects compared to non-selective NSAIDs. Benefits include rapid pain reduction, improved mobility, and better safety profile for long-term use.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Etoricoxib tablets are approved in the EU for managing rheumatoid arthritis, osteoarthritis, and gout. In the EU, brands like Arcoxia are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, etoricoxib is not approved by the FDA but is marketed in certain countries outside the US. Both regions require comprehensive dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for etoricoxib tablets, ensuring adherence to European standards for safe, effective pain and inflammation management.

Etoricoxib Tablets — third party manufacturing & bulk supply

Etoricoxib Tablets 60 mg, 90 mg, 120 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Etoricoxib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Etoricoxib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Etoricoxib Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Etoricoxib tablets is listed as Tablets in 60 mg, 90 mg, 120 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Etoricoxib tablets is referenced against Arcoxia (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Etoricoxib tablets is catalogued under Arthritis on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Pegloticase Injecatble

Strength:
8 mg/1.2 mL vial

Form: Injectable (IV solution)

Reference Brands: Krystexxa (US)

View Details
Colchicine Tablest

Strength:
0.6 mg

Form: Tablet

Reference Brands: Colcrys(US)

View Details
Febuxostat Tablets

Strength:
40 mg, 80 mg

Form: Oral Tablets

Reference Brands: Uloric(EU & US)

View Details
Allopurinol Tablets

Strength:
100 mg, 300 mg

Form: Oral Tablets

Reference Brands: Aloprim(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.